We are live on ! Find out more
AGN

Allergan plc
AGN

Delisted

AGN was delisted on the 8th of May, 2020.

1,048 hedge funds and large institutions have $44.5B invested in Allergan plc in 2017 Q4 according to their latest regulatory filings, with 168 funds opening new positions, 313 increasing their positions, 479 reducing their positions, and 200 closing their positions.

New
Increased
Maintained
Reduced
Closed

4% less funds holding

Funds holding: 1,0901,048 (-42)

16% less first-time investments, than exits

New positions opened: 168 | Existing positions closed: 200

18% less funds holding in top 10

Funds holding in top 10: 4940 (-9)

21% less capital invested

Capital invested by funds: $56B → $44.5B (-$11.5B)

34% less call options, than puts

Call options by funds: $1.32B | Put options by funds: $2B

35% less repeat investments, than reductions

Existing positions increased: 313 | Existing positions reduced: 479

Holders
1,048
Holders Change
-42
Holders Change %
-3.85%
% of All Funds
23.76%
Holding in Top 10
40
Holding in Top 10 Change
-9
Holding in Top 10 Change %
-18.37%
% of All Funds
0.91%
New
168
Increased
313
Reduced
479
Closed
200
Calls
$1.32B
Puts
$2B
Net Calls
-$681M
Net Calls Change
+$259M
Name Holding Trade Value Shares
Change
Change in
Stake
YP
801
Yellowstone Partners
Idaho
$329K -$143K -796 -28%
HHC
802
Hutchin Hill Capital
New York
$327K -$8.88M -49,500 -96%
CCM
803
Chickasaw Capital Management
Tennessee
$327K
KCM
804
KSA Capital Management
New Jersey
$327K
SPC
805
Sigma Planning Corp
Michigan
$327K +$190K +1,061 +66%
BCP
806
Blackhawk Capital Partners
Wisconsin
$327K +$359K +2,000 New
TMAM
807
Tokio Marine Asset Management
Japan
$326K -$121K -673 -25%
SMC
808
Smith, Moore & Co
Missouri
$326K +$38.2K +213 +12%
PFS
809
Prospera Financial Services
Texas
$326K +$341K +1,898 New
NRS
810
Neville Rodie & Shaw
New York
$322K -$149K -830 -30%
YIA
811
YHB Investment Advisors
Connecticut
$321K -$169K -940 -32%
CCA
812
Checchi Capital Advisers
California
$321K -$45.9K -256 -12%
SM
813
Sciencast Management
New Jersey
$320K +$3.95K +22 +1%
BCM
814
Bienville Capital Management
New York
$319K +$45K +251 +15%
BWM
815
Buckley Wealth Management
Nevada
$317K +$348K +1,938 New
FFWA
816
FRG Family Wealth Advisors
Washington
$316K +$346K +1,930 New
AFP
817
Ausdal Financial Partners
Iowa
$311K +$137K +765 +67%
KFA
818
Kelleher Financial Advisors
New York
$310K -$3.77K -21 -1%
RFA
819
Reilly Financial Advisors
California
$302K -$7.46M -41,570 -96%
IWM
820
IHT Wealth Management
Illinois
$298K -$372K -2,071 -54%
SBL
821
Sargent Bickham Lagudis
Colorado
$290K -$370K -2,061 -54%
BWA
822
BDO Wealth Advisors
Florida
$290K +$22.4K +125 +8%
TRCT
823
Tower Research Capital (TRC)
New York
$289K +$263K +1,463 +480%
GT
824
Greenleaf Trust
Michigan
$288K +$41.1K +229 +15%
SWM
825
SeaCrest Wealth Management
New York
$288K +$316K +1,760 New

AGN Hedge Fund Activity: Q4 2017 in Review

1,048 of the 4,410 institutional investors tracked by Wall St. Rank reported a position in Allergan plc (AGN) for Q4 2017, worth a combined $44.5B — down 21% from $56B a quarter earlier.

Sellers outnumbered buyers: 200 funds closed out of AGN and 168 opened new positions — a net loss of 32 holders — while 479 trimmed existing stakes and 313 added.

The largest buyer was Southeastern Asset Management, opening a new position worth an estimated $412M. The largest seller was Fidelity Investments, cutting an estimated $699M.

  • 1,048 institutional investors held Allergan plc (AGN) as of Q4 2017, down from 1,090 in Q3 2017.
  • Funds reported $44.5B of Allergan plc stock for Q4 2017, down 21% quarter-over-quarter.
  • 168 funds opened new Allergan plc positions in Q4 2017 and 200 closed out, a net change of -32 holders.
  • The largest Allergan plc buyer in Q4 2017 was Southeastern Asset Management, an estimated $412M added.
  • The largest Allergan plc seller in Q4 2017 was Fidelity Investments, an estimated $699M sold.

Based on aggregated 13F filings for Q4 2017.